- Home
- HSHP vs LUNG Comparison
HSHP vs LUNG Comparison
Compare HSHP & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSHP
- LUNG
- Stock Information
- Founded
- HSHP 2021
- LUNG 1995
- Country
- HSHP Bermuda
- LUNG United States
- Employees
- HSHP N/A
- LUNG N/A
- Industry
- HSHP
- LUNG Industrial Specialties
- Sector
- HSHP
- LUNG Health Care
- Exchange
- HSHP Nasdaq
- LUNG Nasdaq
- Market Cap
- HSHP 268.6M
- LUNG 65.6M
- IPO Year
- HSHP 2023
- LUNG 2020
- Fundamental
- Price
- HSHP $8.72
- LUNG $1.55
- Analyst Decision
- HSHP
- LUNG Buy
- Analyst Count
- HSHP 0
- LUNG 7
- Target Price
- HSHP N/A
- LUNG $7.66
- AVG Volume (30 Days)
- HSHP 135.5K
- LUNG 480.4K
- Earning Date
- HSHP 08-08-2025
- LUNG 10-29-2025
- Dividend Yield
- HSHP 5.13%
- LUNG N/A
- EPS Growth
- HSHP N/A
- LUNG N/A
- EPS
- HSHP 0.14
- LUNG N/A
- Revenue
- HSHP $120,680,000.00
- LUNG $90,549,000.00
- Revenue This Year
- HSHP $7.10
- LUNG $10.30
- Revenue Next Year
- HSHP $26.34
- LUNG $14.72
- P/E Ratio
- HSHP $64.77
- LUNG N/A
- Revenue Growth
- HSHP 44.77
- LUNG 18.24
- 52 Week Low
- HSHP $4.29
- LUNG $1.47
- 52 Week High
- HSHP $8.87
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- HSHP 77.79
- LUNG 37.40
- Support Level
- HSHP $8.08
- LUNG $1.60
- Resistance Level
- HSHP $8.87
- LUNG $1.76
- Average True Range (ATR)
- HSHP 0.15
- LUNG 0.13
- MACD
- HSHP 0.06
- LUNG 0.02
- Stochastic Oscillator
- HSHP 89.13
- LUNG 2.86
About HSHP Himalaya Shipping Ltd.
Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.